Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect-site controlled, reaction-time safeguarded, patient-maintained propofol sedation
2005-005758-39Phase 4Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in anxiety disorder, sponsored by NHS Greater Glasgow and Clyde. Primary endpoints: Maximal change in oxygen saturation (SpO2), Maximal change in respiratory rate (RR) and 1 more. Started Sep 2006; status: terminated.
02
Drugs
propofol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2005-005758-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005758-39.